Uncovering the Lipid Web: Discovering the Multifaceted Roles of Lipids in Human Diseases and Therapeutic Opportunities
1. Introduction
- A. Unleashing lipid power: Exploring cholesterol and specialized proresolving lipid mediators for cardiovascular Health.
- B. Unraveling the complexities of lipids: Insights into obesity-related diseases.
- C. Unveiling the complexities of lipid metabolism in cancer: Implications for therapeutic strategies.
- D. Deciphering lipid dynamics in neuroinflammatory and neurodegenerative diseases.
2. Conclusions
Acknowledgments
Conflicts of Interest
References
- Killian, J.A. Hydrophobic mismatch between proteins and lipids in membranes. Biochim. Biophys. Acta (BBA)-Rev. Biomembr. 1998, 1376, 401–416. [Google Scholar] [CrossRef]
- Kuroda, K.; Caputo, G.A.; DeGrado, W.F. The Role of Hydrophobicity in the Antimicrobial and Hemolytic Activities of Polymethacrylate Derivatives. Chem.–Eur. J. 2009, 15, 1123–1133. [Google Scholar] [CrossRef] [PubMed]
- Glatz, J.F.C.; Luiken, J.J.F.P. Fatty acids in cell signaling: Historical perspective and future outlook. Prostaglandins Leukot. Essent. Fat. Acids 2015, 92, 57–62. [Google Scholar] [CrossRef] [PubMed]
- Brenner, R.R.; Peluffo, R.O. Effect of Saturated and Unsaturated Fatty Acids on the Desaturation in Vitro of Palmitic, Stearic, Oleic, Linoleic, and Linolenic Acids. J. Biol. Chem. 1966, 241, 5213–5219. [Google Scholar] [CrossRef] [PubMed]
- De Carvalho, C.C.C.R.; Caramujo, M.J. The Various Roles of Fatty Acids. Molecules 2018, 23, 2583. [Google Scholar] [CrossRef]
- Jones, S.F.; Infante, J.R. Molecular Pathways: Fatty Acid Synthase. Clin. Cancer Res. 2015, 21, 5434–5438. [Google Scholar] [CrossRef] [PubMed]
- Calder, P.C. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot. Essent. Fat. Acids 2008, 79, 101–108. [Google Scholar] [CrossRef]
- Schouten, S.; Hopmans, E.C.; Sinninghe Damsté, J.S. The organic geochemistry of glycerol dialkyl glycerol tetraether lipids: A review. Org. Geochem. 2013, 54, 19–61. [Google Scholar] [CrossRef]
- Langworthy, T.A.; Smith, P.F.; Mayberry, W.R. Lipids of Thermoplasma acidophilum. J. Bacteriol. 1972, 112, 1193–1200. [Google Scholar] [CrossRef]
- Langworthy, T.A.; Tornabene, T.G.; Holzer, G. Lipids of Archaebacteria. Zentralblatt Für Bakteriol. Mikrobiol. Hyg. I. Abt. Orig. C Allg. Angew. Okol. Mikrobiol. 1982, 3, 228–244. [Google Scholar] [CrossRef]
- Dufourc, E.J. Sterols and membrane dynamics. J. Chem. Biol. 2008, 1, 63–77. [Google Scholar] [CrossRef] [PubMed]
- Mesmin, B.; Maxfield, F.R. Intracellular sterol dynamics. Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 2009, 1791, 636–645. [Google Scholar] [CrossRef]
- Lv, Q.-Z.; Yan, L.; Jiang, Y.-Y. The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn. Virulence 2016, 7, 649–659. [Google Scholar] [CrossRef] [PubMed]
- Bangham, A.D. Membrane models with phospholipids. Prog. Biophys. Mol. Biol. 1968, 18, 29–95. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Wang, X.; Zhang, T.; Wang, C.; Huang, Z.; Luo, X.; Deng, Y. A review on phospholipids and their main applications in drug delivery systems. Asian J. Pharm. Sci. 2015, 10, 81–98. [Google Scholar] [CrossRef]
- Pichot, R.; Watson, R.L.; Norton, I.T. Phospholipids at the Interface: Current Trends and Challenges. Int. J. Mol. Sci. 2013, 14, 11767–11794. [Google Scholar] [CrossRef]
- Ray, T.K.; Skipski, V.P.; Barclay, M.; Essner, E.; Archibald, F.M. Lipid Composition of Rat Liver Plasma Membranes. J. Biol. Chem. 1969, 244, 5528–5536. [Google Scholar] [CrossRef]
- Yu, J.; Fischman, D.A.; Steck, T.L. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J. Supramol. Struct. 1973, 1, 233–248. [Google Scholar] [CrossRef]
- Spolarics, Z.; Lang, C.H.; Bagby, G.J.; Spitzer, J.J. Glutamine and fatty acid oxidation are the main sources of energy for Kupffer and endothelial cells. Am. J. Physiol.-Gastrointest. Liver Physiol. 1991, 261, G185–G190. [Google Scholar] [CrossRef]
- Valente, L.M.P.; Linares, F.; Villanueva, J.L.R.; Silva, J.M.G.; Espe, M.; Escórcio, C.; Pires, M.A.; Saavedra, M.J.; Borges, P.; Medale, F.; et al. Dietary protein source or energy levels have no major impact on growth performance, nutrient utilisation or flesh fatty acids composition of market-sized Senegalese sole. Aquaculture 2011, 318, 128–137. [Google Scholar] [CrossRef]
- Yang, A.; Mottillo, E.P. Adipocyte lipolysis: From molecular mechanisms of regulation to disease and therapeutics. Biochem. J. 2020, 477, 985–1008. [Google Scholar] [CrossRef] [PubMed]
- Small, D.M. A classification of biologic lipids based upon their interaction in aqueous systems. J. Am. Oil Chem. Soc. 1968, 45, 108–119. [Google Scholar] [CrossRef] [PubMed]
- Shvartsburg, A.A.; Isaac, G.; Leveque, N.; Smith, R.D.; Metz, T.O. Separation and Classification of Lipids Using Differential Ion Mobility Spectrometry. J. Am. Soc. Mass Spectrom. 2011. [Google Scholar] [CrossRef]
- Ono, T.; Imai, Y. Effects of Steroid Hormones on Synthesis of Cholesterol in vitro. J. Biochem. 1971, 70, 45–54. [Google Scholar] [CrossRef]
- Cole, T.J.; Short, K.L.; Hooper, S.B. The science of steroids. Semin. Fetal Neonatal Med. 2019, 24, 170–175. [Google Scholar] [CrossRef] [PubMed]
- Gillberg, C.; Fernell, E.; Kočovská, E.; Minnis, H.; Bourgeron, T.; Thompson, L.; Allely, C.S. The role of cholesterol metabolism and various steroid abnormalities in autism spectrum disorders: A hypothesis paper. Autism Res. 2017, 10, 1022–1044. [Google Scholar] [CrossRef]
- Hu, J.; Zhang, Z.; Shen, W.-J.; Azhar, S. Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones. Nutr. Metab. 2010, 7, 47. [Google Scholar] [CrossRef]
- Reboul, E.; Borel, P. Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes. Prog. Lipid Res. 2011, 50, 388–402. [Google Scholar] [CrossRef]
- Meydani, M.; Martin, K.R. Intestinal Absorption of Fat-Soluble Vitamins. In Intestinal Lipid Metabolism; Mansbach, C.M., Tso, P., Kuksis, A., Eds.; Springer: Boston, MA, USA, 2001; pp. 367–381. [Google Scholar]
- Sokol, R.J. Fat-Soluble Vitamins and Their Importance in Patients with Cholestatic Liver Diseases. Gastroenterol. Clin. N. Am. 1994, 23, 673–705. [Google Scholar] [CrossRef]
- Chew, H.; Solomon, V.A.; Fonteh, A.N. Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies. Front Physiol 2020, 11, 598. [Google Scholar] [CrossRef]
- Dakterzada, F.; Benítez, I.D.; Targa, A.; Carnes, A.; Pujol, M.; Jové, M.; Mínguez, O.; Vaca, R.; Sánchez-de-la-Torre, M.; Barbé, F.; et al. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease. Alzheimers Res. Ther. 2023, 15, 134. [Google Scholar] [CrossRef] [PubMed]
- Belarbi, K.; Cuvelier, E.; Bonte, M.A.; Desplanque, M.; Gressier, B.; Devos, D.; Chartier-Harlin, M.C. Glycosphingolipids and neuroinflammation in Parkinson’s disease. Mol Neurodegener 2020, 15, 59. [Google Scholar] [CrossRef] [PubMed]
- Block, R.C.; Dorsey, E.R.; Beck, C.A.; Brenna, J.T.; Shoulson, I. Altered cholesterol and fatty acid metabolism in Huntington disease. Journal of Clinical Lipidology 2010, 4, 17–23. [Google Scholar] [CrossRef] [PubMed]
- Hunter, M.; Demarais, N.J.; Faull, R.L.M.; Grey, A.C.; Curtis, M.A. An imaging mass spectrometry atlas of lipids in the human neurologically normal and Huntington’s disease caudate nucleus. Journal of Neurochemistry 2021, 157, 2158–2172. [Google Scholar] [CrossRef] [PubMed]
- Li, M.; Chi, X.; Wang, Y.; Setrerrahmane, S.; Xie, W.; Xu, H. Trends in insulin resistance: Insights into mechanisms and therapeutic strategy. Signal Transduction and Targeted Therapy 2022, 7, 216. [Google Scholar] [CrossRef] [PubMed]
- Di Pino, A.; DeFronzo, R.A. Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocrine Reviews 2019, 40, 1447–1467. [Google Scholar] [CrossRef]
- Roth, G.A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S.F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J. Am. Coll. Cardiol. 2017, 70, 1–25. [Google Scholar] [CrossRef] [PubMed]
- Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; Das, S.R.; De Ferranti, S.; Després, J.-P.; Fullerton, H.J. Heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation 2016, 133, e38–e360. [Google Scholar] [CrossRef] [PubMed]
- Toth, P.P. Reverse cholesterol transport: High-density lipoprotein’s magnificent mile. Curr. Atheroscler. Rep. 2003, 5, 386–393. [Google Scholar] [CrossRef]
- Wadhera, R.K.; Steen, D.L.; Khan, I.; Giugliano, R.P.; Foody, J.M. A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality. J. Clin. Lipidol. 2016, 10, 472–489. [Google Scholar] [CrossRef]
- Assmann, G.; Schulte, H.; von Eckardstein, A. Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am. J. Cardiol. 1996, 77, 1179–1184. [Google Scholar] [CrossRef]
- Lin, Y.; Mousa, S.S.; Elshourbagy, N.; Mousa, S.A. Current status and future directions in lipid management: Emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy. Vasc. Health Risk Manag. 2010, 6, 73–85. [Google Scholar] [CrossRef] [PubMed]
- Balling, M.; Afzal, S.; Davey Smith, G.; Varbo, A.; Langsted, A.; Kamstrup, P.R.; Nordestgaard, B.G. Elevated LDL Triglycerides and Atherosclerotic Risk. J. Am. Coll. Cardiol. 2023, 81, 136–152. [Google Scholar] [CrossRef] [PubMed]
- Yuan, S.; Tang, B.; Zheng, J.; Larsson, S.C. Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke. Ann. Neurol. 2020, 88, 1229–1236. [Google Scholar] [CrossRef] [PubMed]
- Ganda, O.P. Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease. Curr. Opin. Lipidol. 2023, 34, 105–113. [Google Scholar] [CrossRef] [PubMed]
- Halldin, A.-K.; Lissner, L.; Lernfelt, B.; Björkelund, C. Cholesterol and triglyceride levels in midlife and risk of heart failure in women, a longitudinal study: The prospective population study of women in Gothenburg. BMJ Open 2020, 10, e036709. [Google Scholar] [CrossRef]
- Harchaoui, K.E.; Visser, M.E.; Kastelein, J.J.; Stroes, E.S.; Dallinga-Thie, G.M. Triglycerides and cardiovascular risk. Curr. Cardiol. Rev. 2009, 5, 216–222. [Google Scholar] [CrossRef]
- Szatmary, P.; Grammatikopoulos, T.; Cai, W.; Huang, W.; Mukherjee, R.; Halloran, C.; Beyer, G.; Sutton, R. Acute Pancreatitis: Diagnosis and Treatment. Drugs 2022, 82, 1251–1276. [Google Scholar] [CrossRef]
- Sugano, M.; Tsuchida, K.; Makino, N. High-density lipoproteins protect endothelial cells from tumor necrosis factor-α-induced apoptosis. Biochem. Biophys. Res. Commun. 2000, 272, 872–876. [Google Scholar] [CrossRef]
- Kontush, A.; Chapman, M.J. Antiatherogenic function of HDL particle subpopulations: Focus on antioxidative activities. Curr. Opin. Lipidol. 2010, 21, 312–318. [Google Scholar] [CrossRef]
- Barter, P.J.; Nicholls, S.; Rye, K.-A.; Anantharamaiah, G.; Navab, M.; Fogelman, A.M. Antiinflammatory properties of HDL. Circ. Res. 2004, 95, 764–772. [Google Scholar] [CrossRef] [PubMed]
- Mineo, C.; Deguchi, H.; Griffin, J.H.; Shaul, P.W. Endothelial and antithrombotic actions of HDL. Circ. Res. 2006, 98, 1352–1364. [Google Scholar] [CrossRef] [PubMed]
- Halade, G.V.; Kain, V.; Tourki, B.; Jadapalli, J.K. Lipoxygenase drives lipidomic and metabolic reprogramming in ischemic heart failure. Metabolism 2019, 96, 22–32. [Google Scholar] [CrossRef] [PubMed]
- Halade, G.V.; Kain, V.; Ingle, K.A.; Prabhu, S.D. Interaction of 12/15-lipoxygenase with fatty acids alters the leukocyte kinetics leading to improved postmyocardial infarction healing. Am. J. Physiol.-Heart Circ. Physiol. 2017, 313, H89–H102. [Google Scholar] [CrossRef] [PubMed]
- Salazar, J.; Pirela, D.; Nava, M.; Castro, A.; Angarita, L.; Parra, H.; Durán-Agüero, S.; Rojas-Gómez, D.M.; Galbán, N.; Añez, R.; et al. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Int. J. Mol. Sci. 2022, 23, 3133. [Google Scholar] [CrossRef] [PubMed]
- Luef, G.; Rauchenzauner, M.; Waldmann, M.; Sturm, W.; Sandhofer, A.; Seppi, K.; Trinka, E.; Unterberger, I.; Ebenbichler, C.F.; Joannidis, M.; et al. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. Epilepsy Res. 2009, 86, 42–47. [Google Scholar] [CrossRef]
- Pandey, M.K. Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms of Neuroinflammation in Lysosomal Storage Diseases. Biomedicines 2023, 11, 1067. [Google Scholar] [CrossRef]
- Jaiswal, M.; Schinske, A.; Pop-Busui, R. Lipids and lipid management in diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 2014, 28, 325–338. [Google Scholar] [CrossRef]
- Palavicini, J.P.; Chen, J.; Wang, C.; Wang, J.; Qin, C.; Baeuerle, E.; Wang, X.; Woo, J.A.; Kang, D.E.; Musi, N.; et al. Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes. JCI Insight 2020, 5. [Google Scholar] [CrossRef]
- Carmena, R. Type 2 diabetes, dyslipidemia, and vascular risk: Rationale and evidence for correcting the lipid imbalance. Am. Heart J. 2005, 150, 859–870. [Google Scholar] [CrossRef]
- Dorochow, E.; Kraus, N.; Chenaux-Repond, N.; Pierre, S.; Kolbinger, A.; Geisslinger, G.; Ortiz, C.; Welsch, C.; Trebicka, J.; Gurke, R.; et al. Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice. Int. J. Mol. Sci. 2023, 24, 10351. [Google Scholar] [CrossRef] [PubMed]
- Höring, M.; Peschel, G.; Grimm, J.; Krautbauer, S.; Müller, M.; Weigand, K.; Liebisch, G.; Buechler, C. Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection. Int. J. Mol. Sci. 2022, 23, 9806. [Google Scholar] [CrossRef] [PubMed]
- Saunders, J.; Sikder, K.; Phillips, E.; Ishwar, A.; Mothy, D.; Margulies, K.B.; Choi, J.C. Med25 Limits Master Regulators That Govern Adipogenesis. Int. J. Mol. Sci. 2023, 24, 6155. [Google Scholar] [CrossRef] [PubMed]
- Thangavel, H.; Dhanyalayam, D.; Lizardo, K.; Oswal, N.; Dolgov, E.; Perlin, D.S.; Nagajyothi, J.F. Susceptibility of Fat Tissue to SARS-CoV-2 Infection in Female hACE2 Mouse Model. Int. J. Mol. Sci. 2023, 24, 1314. [Google Scholar] [CrossRef] [PubMed]
- Petan, T.; Jarc, E.; Jusović, M. Lipid Droplets in Cancer: Guardians of Fat in a Stressful World. Molecules 2018, 23, 1941. [Google Scholar] [CrossRef] [PubMed]
- Martinez-Lopez, N.; Singh, R. Autophagy and Lipid Droplets in the Liver. Annu. Rev. Nutr. 2015, 35, 215–237. [Google Scholar] [CrossRef] [PubMed]
- Maan, M.; Peters, J.M.; Dutta, M.; Patterson, A.D. Lipid metabolism and lipophagy in cancer. Biochem. Biophys. Res. Commun. 2018, 504, 582–589. [Google Scholar] [CrossRef]
- Alizadeh, J.; Kavoosi, M.; Singh, N.; Lorzadeh, S.; Ravandi, A.; Kidane, B.; Ahmed, N.; Mraiche, F.; Mowat, M.R.; Ghavami, S. Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer. Cancers 2023, 15, 2195. [Google Scholar] [CrossRef]
- Turchi, R.; Tortolici, F.; Benvenuto, M.; Punziano, C.; De Luca, A.; Rufini, S.; Faraonio, R.; Bei, R.; Lettieri-Barbato, D.; Aquilano, K. Low Sulfur Amino Acid, High Polyunsaturated Fatty Acid Diet Inhibits Breast Cancer Growth. Int. J. Mol. Sci. 2023, 24, 249. [Google Scholar] [CrossRef]
- Luo, S.-D.; Tsai, H.-T.; Chiu, T.-J.; Li, S.-H.; Hsu, Y.-L.; Su, L.-J.; Tsai, M.-H.; Lee, C.-Y.; Hsiao, C.-C.; Chen, C.-H. Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma. Int. J. Mol. Sci. 2022, 23, 5700. [Google Scholar] [CrossRef]
- Zhang, J.; Liu, Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell 2015, 6, 254–264. [Google Scholar] [CrossRef] [PubMed]
- Ledeen, R.; Chowdhury, S. Gangliosides in Neurodegenerative Diseases. Adv. Neurobiol. 2023, 29, 391–418. [Google Scholar] [CrossRef] [PubMed]
- Wallom, K.L.; Fernández-Suárez, M.E.; Priestman, D.A.; Te Vruchte, D.; Huebecker, M.; Hallett, P.J.; Isacson, O.; Platt, F.M. Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease. Glycoconj. J. 2022, 39, 39–53. [Google Scholar] [CrossRef] [PubMed]
- Magnusen, A.F.; Hatton, S.L.; Rani, R.; Pandey, M.K. Genetic Defects and Pro-inflammatory Cytokines in Parkinson’s Disease. Front. Neurol. 2021, 12, 636139. [Google Scholar] [CrossRef] [PubMed]
- Hatton, S.L.; Pandey, M.K. Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease. Int. J. Mol. Sci. 2022, 23, 1089. [Google Scholar] [CrossRef] [PubMed]
- Sturchio, A.; Dwivedi, A.K.; Vizcarra, J.A.; Chirra, M.; Keeling, E.G.; Mata, I.F.; Kauffman, M.A.; Pandey, M.K.; Roviello, G.; Comi, C.; et al. Genetic parkinsonisms and cancer: A systematic review and meta-analysis. Rev. Neurosci. 2021, 32, 159–167. [Google Scholar] [CrossRef] [PubMed]
- Czubowicz, K.; Jęśko, H.; Wencel, P.; Lukiw, W.J.; Strosznajder, R.P. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer’s Disease and Other Neurodegenerative Disorders. Mol. Neurobiol. 2019, 56, 5436–5455. [Google Scholar] [CrossRef] [PubMed]
- Yanagisawa, K. GM1 ganglioside and Alzheimer’s disease. Glycoconj. J. 2015, 32, 87–91. [Google Scholar] [CrossRef]
- Grassi, S.; Giussani, P.; Mauri, L.; Prioni, S.; Sonnino, S.; Prinetti, A. Lipid rafts and neurodegeneration: Structural and functional roles in physiologic aging and neurodegenerative diseases. J. Lipid Res. 2020, 61, 636–654. [Google Scholar] [CrossRef]
- Mesa-Herrera, F.; Taoro-González, L.; Valdés-Baizabal, C.; Diaz, M.; Marín, R. Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers. Int. J. Mol. Sci. 2019, 20, 3810. [Google Scholar] [CrossRef]
- Marin, R.; Fabelo, N.; Fernández-Echevarría, C.; Canerina-Amaro, A.; Rodríguez-Barreto, D.; Quinto-Alemany, D.; Mesa-Herrera, F.; Díaz, M. Lipid Raft Alterations in Aged-Associated Neuropathologies. Curr. Alzheimer Res. 2016, 13, 973–984. [Google Scholar] [CrossRef] [PubMed]
- Martín, V.; Fabelo, N.; Santpere, G.; Puig, B.; Marín, R.; Ferrer, I.; Díaz, M. Lipid alterations in lipid rafts from Alzheimer’s disease human brain cortex. J. Alzheimers Dis. 2010, 19, 489–502. [Google Scholar] [CrossRef] [PubMed]
- Li, H.; Huynh, T.N.; Duong, M.T.; Gow, J.G.; Chang, C.C.Y.; Chang, T.Y. ACAT1/SOAT1 Blockade Suppresses LPS-Mediated Neuroinflammation by Modulating the Fate of Toll-like Receptor 4 in Microglia. Int. J. Mol. Sci. 2023, 24, 5616. [Google Scholar] [CrossRef] [PubMed]
- Harned, T.C.; Stan, R.V.; Cao, Z.; Chakrabarti, R.; Higgs, H.N.; Chang, C.C.Y.; Chang, T.Y. Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity. Int. J. Mol. Sci. 2023, 24, 5525. [Google Scholar] [CrossRef] [PubMed]
- Batarseh, A.M.; Vafaee, F.; Hosseini-Beheshti, E.; Safarchi, A.; Chen, A.; Cohen, A.; Juillard, A.; Hunt, N.H.; Mariani, M.; Mitchell, T.; et al. Investigation of Plasma-Derived Lipidome Profiles in Experimental Cerebral Malaria in a Mouse Model Study. Int. J. Mol. Sci. 2023, 24, 501. [Google Scholar] [CrossRef] [PubMed]
- Pandey, M.K.; Grabowski, G.A.; Köhl, J. An unexpected player in Gaucher disease: The multiple roles of complement in disease development. Semin Immunol 2018, 37, 30–42. [Google Scholar] [CrossRef] [PubMed]
- Pandey, M.K.; Burrow, T.A.; Rani, R.; Martin, L.J.; Witte, D.; Setchell, K.D.; McKay, M.A.; Magnusen, A.F.; Zhang, W.; Liou, B.; et al. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. Nature 2017, 543, 108–112. [Google Scholar] [CrossRef]
- Serfecz, J.C.; Saadin, A.; Santiago, C.P.; Zhang, Y.; Bentzen, S.M.; Vogel, S.N.; Feldman, R.A. C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages. Int. J. Mol. Sci. 2021, 22, 9912. [Google Scholar] [CrossRef]
- Vergès, B. Lipid modification in type 2 diabetes: The role of LDL and HDL. Fundam. Clin. Pharmacol. 2009, 23, 681–685. [Google Scholar] [CrossRef]
- Lee, S.; Zhou, J.; Wong, W.T.; Liu, T.; Wu, W.K.K.; Wong, I.C.K.; Zhang, Q.; Tse, G. Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning. BMC Endocr. Disord. 2021, 21, 94. [Google Scholar] [CrossRef]
- Guo, X.; Zhang, T.; Shi, L.; Gong, M.; Jin, J.; Zhang, Y.; Liu, R.; Chang, M.; Jin, Q.; Wang, X. The relationship between lipid phytochemicals, obesity and its related chronic diseases. Food Funct. 2018, 9, 6048–6062. [Google Scholar] [CrossRef] [PubMed]
- Friedland, O.; Nemet, D.; Gorodnitsky, N.; Wolach, B.; Eliakim, A. Obesity and lipid profiles in children and adolescents. J. Pediatr. Endocrinol. Metab. 2002, 15, 1011–1016. [Google Scholar] [CrossRef] [PubMed]
- Martin-Perez, M.; Urdiroz-Urricelqui, U.; Bigas, C.; Benitah, S.A. The role of lipids in cancer progression and metastasis. Cell Metab. 2022, 34, 1675–1699. [Google Scholar] [CrossRef] [PubMed]
- Butler, L.M.; Perone, Y.; Dehairs, J.; Lupien, L.E.; de Laat, V.; Talebi, A.; Loda, M.; Kinlaw, W.B.; Swinnen, J.V. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv. Drug Deliv. Rev. 2020, 159, 245–293. [Google Scholar] [CrossRef] [PubMed]
- Wang, G.; Qiu, M.; Xing, X.; Zhou, J.; Yao, H.; Li, M.; Yin, R.; Hou, Y.; Li, Y.; Pan, S.; et al. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis. Sci. Transl. Med. 2022, 14, eabk2756. [Google Scholar] [CrossRef] [PubMed]
- Islam, M.A.; Amin, M.N.; Siddiqui, S.A.; Hossain, M.P.; Sultana, F.; Kabir, M.R. Trans fatty acids and lipid profile: A serious risk factor to cardiovascular disease, cancer and diabetes. Diabetes Metab. Syndr. 2019, 13, 1643–1647. [Google Scholar] [CrossRef]
- Poznyak, A.; Grechko, A.V.; Poggio, P.; Myasoedova, V.A.; Alfieri, V.; Orekhov, A.N. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation. Int. J. Mol. Sci. 2020, 21, 1835. [Google Scholar] [CrossRef]
- Močnik, M.; Marčun Varda, N. Lipid Biomarkers and Atherosclerosis-Old and New in Cardiovascular Risk in Childhood. Int. J. Mol. Sci. 2023, 24, 2237. [Google Scholar] [CrossRef]
- Shaya, G.E.; Leucker, T.M.; Jones, S.R.; Martin, S.S.; Toth, P.P. Coronary heart disease risk: Low-density lipoprotein and beyond. Trends Cardiovasc. Med. 2022, 32, 181–194. [Google Scholar] [CrossRef]
- Wittenbecher, C.; Eichelmann, F.; Toledo, E.; Guasch-Ferré, M.; Ruiz-Canela, M.; Li, J.; Arós, F.; Lee, C.H.; Liang, L.; Salas-Salvadó, J.; et al. Lipid Profiles and Heart Failure Risk: Results From Two Prospective Studies. Circ. Res. 2021, 128, 309–320. [Google Scholar] [CrossRef]
- Cordy, R.J.; Patrapuvich, R.; Lili, L.N.; Cabrera-Mora, M.; Chien, J.T.; Tharp, G.K.; Khadka, M.; Meyer, E.V.; Lapp, S.A.; Joyner, C.J.; et al. Distinct amino acid and lipid perturbations characterize acute versus chronic malaria. JCI Insight 2019. [Google Scholar] [CrossRef] [PubMed]
- Lv, L.; Hai, L.; Wang, Q.; Shi, X. Experimental Cerebral Malaria Alters Blood Lipid Levels During Pathogenesis. J. Parasitol. 2019, 105, 401–407. [Google Scholar] [CrossRef] [PubMed]
- Chen, Z.P.; Wang, S.; Zhao, X.; Fang, W.; Wang, Z.; Ye, H.; Wang, M.J.; Ke, L.; Huang, T.; Lv, P.; et al. Lipid-accumulated reactive astrocytes promote disease progression in epilepsy. Nat. Neurosci. 2023, 26, 542–554. [Google Scholar] [CrossRef]
- Pandey, M.K. Pre-existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients. Clin. Transl. Discov. 2022, 2, e96. [Google Scholar] [CrossRef] [PubMed]
- Rezaei, A.; Neshat, S.; Heshmat-Ghahdarijani, K. Alterations of Lipid Profile in COVID-19: A Narrative Review. Curr. Probl. Cardiol. 2022, 47, 100907. [Google Scholar] [CrossRef] [PubMed]
- Kowalska, K.; Sabatowska, Z.; Forycka, J.; Młynarska, E.; Franczyk, B.; Rysz, J. The Influence of SARS-CoV-2 Infection on Lipid Metabolism—The Potential Use of Lipid-Lowering Agents in COVID-19 Management. Biomedicines 2022, 10, 2320. [Google Scholar]
- Theken, K.N.; Tang, S.Y.; Sengupta, S.; FitzGerald, G.A. The roles of lipids in SARS-CoV-2 viral replication and the host immune response. J. Lipid Res. 2021, 62, 100129. [Google Scholar] [CrossRef]
- Kao, Y.C.; Ho, P.C.; Tu, Y.K.; Jou, I.M.; Tsai, K.J. Lipids and Alzheimer’s Disease. Int. J. Mol. Sci. 2020, 21, 1505. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pandey, M.K. Uncovering the Lipid Web: Discovering the Multifaceted Roles of Lipids in Human Diseases and Therapeutic Opportunities. Int. J. Mol. Sci. 2023, 24, 13223. https://doi.org/10.3390/ijms241713223
Pandey MK. Uncovering the Lipid Web: Discovering the Multifaceted Roles of Lipids in Human Diseases and Therapeutic Opportunities. International Journal of Molecular Sciences. 2023; 24(17):13223. https://doi.org/10.3390/ijms241713223
Chicago/Turabian StylePandey, Manoj Kumar. 2023. "Uncovering the Lipid Web: Discovering the Multifaceted Roles of Lipids in Human Diseases and Therapeutic Opportunities" International Journal of Molecular Sciences 24, no. 17: 13223. https://doi.org/10.3390/ijms241713223